355 related articles for article (PubMed ID: 35250981)
1. The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation.
Senev A; Ray B; Lerut E; Hariharan J; Heylen C; Kuypers D; Sprangers B; Emonds MP; Naesens M
Front Immunol; 2022; 13():809059. PubMed ID: 35250981
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.
Callemeyn J; Lerut E; de Loor H; Arijs I; Thaunat O; Koenig A; Meas-Yedid V; Olivo-Marin JC; Halloran P; Chang J; Thorrez L; Kuypers D; Sprangers B; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2168-2183. PubMed ID: 32641395
[TBL] [Abstract][Full Text] [Related]
3. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
4. Antibody-Mediated Rejection Due to Preexisting versus
Aubert O; Loupy A; Hidalgo L; Duong van Huyen JP; Higgins S; Viglietti D; Jouven X; Glotz D; Legendre C; Lefaucheur C; Halloran PF
J Am Soc Nephrol; 2017 Jun; 28(6):1912-1923. PubMed ID: 28255002
[TBL] [Abstract][Full Text] [Related]
5. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation.
Chauhan R; Tiwari AK; Aggarwal G; Gowri Suresh L; Kumar M; Bansal SB
Transpl Immunol; 2023 Dec; 81():101931. PubMed ID: 37730185
[TBL] [Abstract][Full Text] [Related]
6. Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection.
Crespo M; Llinàs-Mallol L; Redondo-Pachón D; Butler C; Gimeno J; Pérez-Sáez MJ; Burballa C; Buxeda A; Arias-Cabrales C; Folgueiras M; Sanz-Ureña S; Valenzuela NM; Reed EF; Pascual J
Front Immunol; 2021; 12():703457. PubMed ID: 34305943
[TBL] [Abstract][Full Text] [Related]
7. Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients.
Lee H; Lee H; Eum SH; Ko EJ; Min JW; Oh EJ; Yang CW; Chung BH
Ann Lab Med; 2023 Jul; 43(4):364-374. PubMed ID: 36843405
[TBL] [Abstract][Full Text] [Related]
8. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
11. The evolution of histological changes suggestive of antibody-mediated injury, in the presence and absence of donor-specific anti-HLA antibodies.
Coemans M; Senev A; Van Loon E; Lerut E; Sprangers B; Kuypers D; Emonds MP; Verbeke G; Naesens M
Transpl Int; 2021 Oct; 34(10):1824-1836. PubMed ID: 34197662
[TBL] [Abstract][Full Text] [Related]
12. Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant.
Kitpermkiat R; Kantachuvesiri S; Thotsiri S; Thammanichanond D; Rostaing L; Wiwattanathum P
Transpl Immunol; 2024 Jun; 84():102054. PubMed ID: 38750972
[TBL] [Abstract][Full Text] [Related]
13. The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation - Data from the Swiss transplant cohort study.
Frischknecht L; Deng Y; Wehmeier C; de Rougemont O; Villard J; Ferrari-Lacraz S; Golshayan D; Gannagé M; Binet I; Wirthmueller U; Sidler D; Schachtner T; Schaub S; Nilsson J;
Front Immunol; 2022; 13():1005790. PubMed ID: 36211367
[TBL] [Abstract][Full Text] [Related]
14. Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes.
Redondo-Pachón D; Pérez-Sáez MJ; Mir M; Gimeno J; Llinás L; García C; Hernández JJ; Yélamos J; Pascual J; Crespo M
Hum Immunol; 2018 Jun; 79(6):424-431. PubMed ID: 29524568
[TBL] [Abstract][Full Text] [Related]
15. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
17. Impact of the immunotherapy induction on allograft outcome and survival in kidney transplant patients with donor-specific antibodies to HLA-DQB1.
Dutra RS; Fabreti-Oliveira RA; Lasmar MF; Araujo SA; Nascimento E
Transpl Immunol; 2021 Jun; 66():101390. PubMed ID: 33838296
[TBL] [Abstract][Full Text] [Related]
18. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
19. Memory B-cell derived donor-specific antibodies do not predict outcome in sensitized kidney transplant recipients: a retrospective single-center study.
Altulea D; van den Born JC; Diepstra A; Bungener L; Terpstra D; Hepkema BG; Lammerts R; Heeringa P; Heidt S; Otten H; Reteig L; Karahan GE; Berger SP; Sanders JS
Front Immunol; 2024; 15():1360627. PubMed ID: 38646525
[TBL] [Abstract][Full Text] [Related]
20. Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients.
Fichtner A; Süsal C; Schröder C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Dragun D; Tönshoff B
Nephrol Dial Transplant; 2018 Jun; 33(6):1065-1072. PubMed ID: 29444269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
